Clinical trials
SARS CoV 2 Infection clinical trials
Below are recruiting sars cov 2 infection clinical trials, each written for real people, not researchers. We’re tracking 63 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07397455RecruitingPhase 1
COVID-19 Omicron Human Challenge Study
This study is a 'human challenge' trial where healthy volunteers who have been vaccinated and have low antibody levels are deliberately exposed to a newer Omicron variant of COVID-19. The goal is to learn how the virus spreads and how to test treatments or vaccines.
LondonAges 18–50 - NCT07343856Enrolling by invitation
Long COVID diagnostic test study
This study is testing a new, non-invasive way to diagnose Long COVID using a simple bioelectrical assessment. It might help if you've had COVID-19 and have been dealing with ongoing symptoms for 12 weeks or longer.
TashkentAges 18–75 - NCT07314905RecruitingPhase 3
Treatments for respiratory infections in community settings
This study is testing different treatments for people with respiratory infections like the flu who are not in the hospital. You may be able to join if you have a positive test, have symptoms like cough or fever, and start within a few days of feeling sick.
Toronto, OntarioAges 18 years+ - NCT07197164RecruitingPhase 2
Remdesivir for kidney transplant patients with mild COVID-19
This trial tests whether giving remdesivir to kidney transplant patients who test positive for COVID-19 can prevent them from getting severely ill. It is for people who have already had at least three COVID-19 vaccine doses and are scheduled to receive a kidney transplant soon.
Badalona, BarcelonaAges 18 years+ - NCT07189936RecruitingPhase 2
Testing 2-HOBA for Immune Issues in Long COVID with POTS
This trial tests if a medication called 2-HOBA can help with ongoing immune system issues in people with Long COVID who also have POTS. It aims to reduce fatigue and other symptoms by calming overactive immune responses.
Nashville, TennesseeAges 18 years+ - NCT05914649Recruiting
Testing long COVID and POTS brain fog symptoms
This study tests how different long-COVID and POTS-related symptoms—especially “brain fog”—show up and improve. It may help researchers better measure symptoms so future treatments can be targeted more effectively.
Calgary, AlbertaAges 18–60 - NCT04815096RecruitingPhase 2
PET scan study of immune activity after COVID-19
This Phase 2 study uses a special PET scan to look at how active your immune system is after a recent COVID-19 infection. The goal is to understand what the immune response looks like and whether this imaging approach could help guide care.
San Francisco, CaliforniaAges 18 years+ - NCT06850350Recruiting
Long COVID and Thinking & Walking
This study looks at how Long COVID affects thinking and movement skills. If you had COVID-19 more than 3 months ago and could walk before you got sick, you may be able to help researchers understand these lasting symptoms.
Chicago, IllinoisAges 18 years+ - NCT06968897Enrolling by invitation
COVID-19 in pregnancy & toddler brain development
This study looks at how COVID-19 infection during pregnancy might affect a toddler's brain development. Researchers will compare children who were exposed to the virus before birth with those who were not.
MarburgAges 3–5 - NCT06099795Recruiting
Breath test vs. swab test for COVID-19
This study checks if a new breath test (eBAM-CoV) can accurately detect COVID-19 compared to the usual nose/throat swab test (RT-PCR). If you have symptoms or were exposed and are getting tested anyway, you may be able to help by also providing a breath sample.
NîmesAges 18 years+ - NCT05973084Recruiting
COVID spread study in Malawi households and vaccine recipients
This study tracks how COVID-19 spreads and causes illness in real households in Blantyre, Malawi, and compares groups after infection or vaccination. If you qualify, you’ll do follow-up testing and visits for several months.
Boston, MassachusettsAges 5–75 - NCT06920628RecruitingPhase 1
Brain scan study for long COVID neurological symptoms
This study uses a special PET scan to look at brain inflammation in people with neurological symptoms after COVID-19. It aims to understand how inflammation might be linked to ongoing problems like brain fog or memory issues.
Bethesda, MarylandAges 18–70 - NCT06848309Recruiting
Immune response study for influenza or COVID-19
This study looks at how your immune system fights off flu or COVID-19. If you have a current or recent infection, or if you've been vaccinated in the past year, you may be able to join.
St Louis, MissouriAges 18–60 - NCT07605520RecruitingEarly Phase 1
COVID-19 Booster Vaccine Study for Previously Vaccinated Adults
This study tests new COVID-19 booster vaccine candidates in healthy adults who previously received mRNA COVID-19 vaccines. Researchers will monitor safety and how well your immune system responds to help develop better COVID-19 protection.
CréteilAges 18–65 - NCT06810934RecruitingPhase 1/Phase 2
New COVID-19 vaccine study for those with prior mRNA vaccines
This study tests a new type of COVID-19 vaccine that is designed to train your immune system to make stronger, longer-lasting protection. You may be able to join if you are 40–64, have already had at least two doses of a mRNA COVID-19 vaccine (Pfizer or Moderna) more than 4 months ago, and are generally healthy.
Los Angeles, CaliforniaAges 40–64 - NCT06684379RecruitingPhase 1/Phase 2
Two Doses of PRS CK STORM for Severe Viral Pneumonia
This study tests a new drug called PRS CK STORM to see if it can safely calm the body's overactive immune response (cytokine storm) in people with severe pneumonia from COVID-19, flu, or RSV who need oxygen. It aims to reduce inflammation and improve recovery.
Alcalá de Henares, MadridAges 18 years+ - NCT06679140RecruitingPhase 3
Study of Ibuzatrelvir for COVID-19 in high-risk patients
This trial tests if a new medicine called ibuzatrelvir can help people with COVID-19 who have certain health risks avoid severe illness. It is for patients who cannot or choose not to take another COVID-19 pill called Paxlovid.
Huntsville, AlabamaAges 12 years+ - NCT06631287RecruitingPhase 3
Testing baricitinib for persistent long COVID symptoms
This trial tests whether the anti-inflammatory drug baricitinib can improve persistent long COVID symptoms like brain fog, fatigue, and shortness of breath. You may qualify if you had COVID-19 at least 6 months ago and still have bothersome symptoms that affect your daily life.
Tucson, ArizonaAges 18 years+ - NCT06577467Recruiting
Studying leftover virus after covid recovery
This study looks for signs of leftover SARS-CoV-2 virus in people who have fully recovered from COVID-19, including those with ongoing neurological symptoms (like brain fog, fatigue, or nerve pain). It aims to understand why some people have long-lasting symptoms after infection.
Bethesda, MarylandAges 18–110 - NCT06402318Recruiting
Quick breath test for COVID, flu, and RSV
This study tests a breathalyzer device that quickly detects COVID-19, flu, and RSV from your breath. If you are already being tested for these viruses, you may join to see if this new method works as well as the usual swab test.
Fort Sam Houston, TexasAges 18–89 - NCT06401720Enrolling by invitation
Flu immune response study by age
This study looks at how the immune system reacts to the flu in people of different ages. If you have flu symptoms and don't have cancer or take immune-suppressing drugs, you may be able to join.
SödertäljeAges 18 years+ - NCT04429594Recruiting
Study tracking COVID-19 infection rates in the public
This study looks at how often SARS-CoV-2 (the virus that causes COVID-19) infection happens in people who may have been exposed in the community. It may help researchers understand infection rates and patterns in the general population.
NiceAges 18 years+ - NCT07659847Recruiting
Heart checkup 5 years after MIS-C
This study looks at the heart health of children and teens who had MIS-C (a rare inflammatory condition linked to COVID-19) about 5 years later. It will compare their results to those of healthy children, to see if there are any lasting effects on the heart.
Warsaw, Masovian VoivodeshipAges Any age - NCT06291870Recruiting
Predicting long-term effects after COVID-19
This study looks at what happens to your thinking and daily health after COVID-19, especially if you have sleep apnea. It aims to find out who is more likely to have ongoing problems.
Detroit, MichiganAges 18 years+
Hear when a new SARS CoV 2 Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
SARS CoV 2 Infection trials by city
Studies with a site in or near these metro areas.
SARS CoV 2 Infection trials by state
Studies with a site anywhere in these states.
Common questions
- Are there clinical trials for sars cov 2 infection?
- Yes. Clin2 currently lists 63 recruiting sars cov 2 infection studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a sars cov 2 infection trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a sars cov 2 infection trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.